Biography for Derek J. Miller: Derek served as Chief Business Officer for Celator Pharmaceuticals from 2013 to mid-2016 when the company was acquired by Jazz Pharmaceuticals. Derek successfully initiated and led business development strategy and execution, resulting in an exit valued at over $1.5B. Derek worked with the leadership team to support fundraising and led the development of the company’s comprehensive corporate strategic plan. Derek also led the company’s internal launch and commercial planning. Derek represented Celator at key industry meetings, including presenting at BIO. Prior to Celator, Derek served in a variety of commercial roles with Genentech from 2006 to 2013, Centocor from 2004 to 2006 and GSK Pharmaceuticals from 1993 to 2004.